TT-301

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameTT-301
Drug Alias NameMW-189TT-301
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlial cells inhibitorsCytokines inhibitors
TargetsCytokines
Therapy Area/IndicationsCerebral HemorrhageBrain Injuries, Traumatic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesTransition Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesJohns Hopkins University
Inactive CompaniesOpko Health IncDuke Clinical Research Institute
Active IndicationsCerebral Hemorrhage
Inactive IndicationsBrain Injuries, Traumatic

Other Information

ATC CodeN/A
Related LinksN/A